Michael W. Depasquale

Insider Reports History

Reporting-owner location: Eagan, MN
Latest reporting-owner signature: /s/ Michael DePasquale
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael W. Depasquale

Form 4 holding Chief Executive Officer, Director, Chairman

BIO KEY INTERNATIONAL INC

Security class: Common Stock
Shares / value: 10,778
Estimated value: $5,712
Report date: 30 Jun 2026
Price: $0.5300
Ownership: Direct

Insider Reports Filed by Michael W. Depasquale

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jul 2026, 16:21
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 31 Dec 2025
Transactions: 1
Transaction value: +$1,150
Accepted by SEC: 05 Jan 2026, 16:44
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4/A BKYI

BIO KEY INTERNATIONAL INC

Report period: 15 Sep 2025
Transactions: 2
Transaction value: +$3,233
Accepted by SEC: 17 Sep 2025, 17:19
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 02 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Sep 2025, 16:40
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Jun 2025
Transactions: 1
Transaction value: +$97.3
Accepted by SEC: 02 Jul 2025, 17:28
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 13 Jun 2025
Transactions: 1
Transaction value: +$3,900
Accepted by SEC: 16 Jun 2025, 08:19
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 03 Jun 2025
Transactions: 1
Transaction value: +$3,320
Accepted by SEC: 04 Jun 2025, 08:30
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 03 Jun 2025
Transactions: 1
Transaction value: +$4,050
Accepted by SEC: 03 Jun 2025, 11:27
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 31 Dec 2024
Transactions: 1
Transaction value: +$195
Accepted by SEC: 03 Jan 2025, 16:07
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4/A BKYI

BIO KEY INTERNATIONAL INC

Report period: 31 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Aug 2024, 17:28
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 31 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Aug 2024, 16:57
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 28 Jun 2024
Transactions: 1
Transaction value: +$194
Accepted by SEC: 02 Jul 2024, 16:57
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 29 Dec 2023
Transactions: 1
Transaction value: +$354
Accepted by SEC: 03 Jan 2024, 17:28
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 04 Dec 2023
Transactions: 1
Transaction value: +$3,600
Accepted by SEC: 04 Dec 2023, 10:12
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Oct 2023
Transactions: 2
Transaction value: +$28,875
Accepted by SEC: 01 Nov 2023, 16:44
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 12 Sep 2023
Transactions: 2
Transaction value: +$2,626
Accepted by SEC: 14 Sep 2023, 13:05
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 29 Aug 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 31 Aug 2023, 16:12
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Jun 2023
Transactions: 1
Transaction value: +$1,243
Accepted by SEC: 05 Jul 2023, 14:11
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 16 Jun 2023
Transactions: 1
Transaction value: +$3,575
Accepted by SEC: 20 Jun 2023, 09:00
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Dec 2022
Transactions: 1
Transaction value: +$1,243
Accepted by SEC: 09 Jan 2023, 10:49
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 15 Sep 2022
Transactions: 1
Transaction value: +$1,688
Accepted by SEC: 16 Sep 2022, 08:42
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 14 Sep 2022
Transactions: 2
Transaction value: +$2,030
Accepted by SEC: 15 Sep 2022, 08:57
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 30 Jun 2022
Transactions: 1
Transaction value: +$3,761
Accepted by SEC: 05 Jul 2022, 15:00
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 14 Jun 2022
Transactions: 1
Transaction value: +$3,320
Accepted by SEC: 15 Jun 2022, 08:30
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 26 May 2022
Transactions: 1
Transaction value: +$4,500
Accepted by SEC: 26 May 2022, 11:46
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 11 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Mar 2022, 16:41
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 31 Dec 2021
Transactions: 1
Transaction value: +$4,700
Accepted by SEC: 04 Jan 2022, 15:43
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 29 Nov 2021
Transactions: 1
Transaction value: +$6,375
Accepted by SEC: 30 Nov 2021, 07:46
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 23 Aug 2021
Transactions: 2
Transaction value: +$6,188
Accepted by SEC: 25 Aug 2021, 16:31
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 16 Jun 2021
Transactions: 1
Transaction value: +$8,000
Accepted by SEC: 17 Jun 2021, 08:02
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

4 BKYI

BIO KEY INTERNATIONAL INC

Report period: 20 May 2021
Transactions: 1
Transaction value: +$17,000
Accepted by SEC: 21 May 2021, 09:26
Role: Chief Executive Officer, Director, Chairman
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .